Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients-Reference-Cited by-同舟云学术

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients

Published:2000 Issue: Volume:11 Page:S113-S116
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Milpied N.,Vasseur B.,Parquet N.,Garnier J.L.,Antoine C.,Quartier P.,Carret A.S.,Bouscary D.,Faye A.,Bourbigot B.,Reguerre Y.,Stoppa A.M.,Bourquard P.,Hurault de Ligny B.,Dubief F.,Mathieu-Boue A.,Leblond V.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/11/suppl_1/S113/7724476/11-suppl_1-S113.pdf

Reference15 articles.

1. Polymorphic diffuse B cell hyperplasias and lymphomas in renal transplant recipients;Frizzera;Cancer Res,1981

2. Reversibility of lymphomas and lymphoproliferative lesions developping under ciclosporine steroid therapy;Starzl;Lancet,1984

3. The international intestinal transplant registry: Current results of intestinal transplantation;Grant;Lancet,1996

4. Epstein–Barr virus lymphoproliferation after bone marrow transplantation;Zutter;Blood,1988

5. The frequency of Epstein–Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children;Ho;Transplantation,1988

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infections in Solid Organ Transplant Recipients;Principles and Practice of Pediatric Infectious Diseases;2023

2. The clinical efficacy of Rituximab administration in autoimmunity disorders, primary immunodeficiency diseases and malignancies;International Immunopharmacology;2021-06

3. The BCL‐2 family protein inhibitor ABT‐737 as an additional tool for the treatment of EBV‐associated post‐transplant lymphoproliferative disorders;Molecular Oncology;2020-08-12

4. Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopes;Virology;2019-10

5. Prevention and Treatment of EBV-Related Complications;Infectious Diseases in Solid-Organ Transplant Recipients;2019